Global Pharmaceutical Traceability Market Size By Technology Type, By Product Type, By Application, By Geographic Scope And Forecast
Published on: 2024-08-04 | No of Pages : 320 | Industry : latest updates trending Report
Publisher : MIR | Format : PDF&Excel
Global Pharmaceutical Traceability Market Size By Technology Type, By Product Type, By Application, By Geographic Scope And Forecast
Pharmaceutical Traceability Market Size And Forecast
Pharmaceutical Traceability Market size was valued at USD 6.42 Billion in 2023 and is projected to reach USD 20.10 Billion by 2030, growing at a CAGR of 17.7% during the forecast period 2024-2030.
Global Pharmaceutical Traceability Market Drivers
The market drivers for the Pharmaceutical Traceability Market can be influenced by various factors. These may include
- Regulatory Compliance Requirements The pharmaceutical industry is adopting traceability solutions due to an increase in regulatory mandates, such as the Falsified Medicines Directive (FMD) in Europe and the Drug Supply Chain Security Act (DSCSA) in the United States. Implementing traceability systems is a requirement for businesses in order to adhere to regulatory standards and guarantee the authenticity and safety of pharmaceutical products all the way through the supply chain.
- Growing Fears About Drug Counterfeiting Growing numbers of fake pharmaceutical products put public health and patient safety at serious risk. Through supply chain visibility, traceability solutions facilitate the authentication of products and aid in the fight against the spread of fake medications.
- Emphasis on Patient Safety and Product Quality By facilitating real-time tracking and monitoring of pharmaceutical products from manufacturing facilities to end users, traceability systems improve both patient safety and product quality. By ensuring that drugs are handled, transported, and stored properly, the chance of contamination or adulteration is reduced.
- Technological Developments The capabilities of pharmaceutical traceability solutions have been improved by ongoing technological developments, including barcode, RFID, serialisation, and data analytics. By facilitating smooth data collection, integration, and analysis throughout the supply chain, these technologies increase transparency and visibility.
- The necessity of supply chain optimisation To cut expenses, boost productivity, and improve inventory control, pharmaceutical companies are concentrating more and more on supply chain optimisation. Solutions for traceability offer insightful information about supply chain procedures, helping businesses to spot bottlenecks, optimise workflow, and reduce interruptions.
- Demand for Track-and-Trace Solutions The need for end-to-end visibility, the complexity of distribution networks, and the globalisation of supply chains are some of the factors driving the growing demand for track-and-trace solutions. To monitor product movement, track ingredient origins, and guarantee regulatory compliance, pharmaceutical companies are investing in traceability technologies.
- A growing number of countries around the world have implemented serialisation mandates, which force pharmaceutical companies to track and identify individual product units or batches in a unique way. The objectives of these mandates are to increase patient safety, prevent drug counterfeiting, and improve product traceability. Pharmaceutical companies are therefore spending money on serialisation solutions in order to comply with regulations and keep access to the market.
- A Growing Emphasis on Supply Chain Safety Pharmaceutical companies now place a high premium on supply chain security due to the rise of global threats like theft, diversion, and tampering. Because they enable quick response to security breaches or incidents, provide insight into product movements, and detect anomalies, traceability solutions are essential to supply chain security.
Global Pharmaceutical Traceability Market Restraints
Several factors can act as restraints or challenges for the Pharmaceutical Traceability Market These may include
- High Upfront Expenses Traceability solutions, which may involve upgrades to infrastructure, software, and hardware, can come with a hefty upfront cost. For some pharmaceutical companies, especially smaller ones with tighter budgets, the expense of acquiring and implementing traceability technologies, along with staff training and system integration, may be a barrier.
- Complexity of Integration It can be difficult and time-consuming to integrate traceability systems with the current manufacturing execution systems (MES), enterprise resource planning (ERP), and other IT infrastructure. Integration complexity can lead to higher implementation costs and longer deployment times, particularly for businesses with decentralised operations or legacy systems.
- Compliance Challenges It can be difficult and resource-intensive to comply with regulatory requirements for data reporting, serialisation, and traceability. Pharmaceutical businesses have to negotiate a complicated web of local laws, serialisation requirements, and data interchange standards that can change depending on the market and the jurisdiction. For businesses with multiple locations, achieving and sustaining compliance with changing regulatory standards can be difficult.
- Legacy Systems and Manual Processes For inventory management, tracking, and documentation, a lot of pharmaceutical companies still rely on manual processes and legacy systems. Organisational change management, employee education, and process redesign are necessary when switching from paper-based to digital traceability solutions. These changes may run against resistance and inertia in conventional organisational structures.
- Data Security and Privacy Issues Traceability systems produce a tonne of sensitive data about patient information, supply chain transactions, and pharmaceutical products. Maintaining the confidentiality, security, and privacy of this data is essential for both regulatory compliance and client confidence. Adoption of traceability solutions may be hampered by worries about data breaches, cyberattacks, and unauthorised access, especially in highly regulated sectors like healthcare.
- Supply Chain Complexity and Fragmentation The manufacturing, distribution, and dispensing of pharmaceutical products are handled by a number of different parties, which results in a fragmented supply chain. Due to variations in systems, procedures, and interoperability standards, managing traceability amongst a wide range of supply chain partners—including manufacturers, wholesalers, distributors, pharmacies, and healthcare providers—can be difficult.
- Limited Interoperability and Standardisation Data interchange and cooperation throughout the supply chain may be hampered by the absence of interoperability and standardisation among traceability systems and data formats. Traceability initiatives may be less effective if there are incompatibilities between various serialisation platforms, communication protocols, and data standards that prevent seamless integration and information sharing.
- Operational Disruptions and Downtime New traceability technology implementations or system upgrades can cause daily operations to be disrupted, which can result in production delays, service interruptions, and downtime. Careful planning, risk mitigation techniques, and backup plans are necessary to minimise operational disruptions during system deployment and migration and to maintain business continuity.
Global Pharmaceutical Traceability Market Segmentation Analysis
The Global Pharmaceutical Traceability Market is Segmented on the basis of Technology Type, Product Type, Application, And Geography.
Pharmaceutical Traceability Market, By Technology Type
- Barcode Involves the use of unique barcodes attached to pharmaceutical products for tracking and tracing purposes.
- Radio-Frequency Identification (RFID) Utilizes RFID tags and readers to track and manage pharmaceutical products throughout the supply chain.
- Serialization Involves assigning unique serial numbers to individual units or batches of pharmaceutical products for traceability.
- Data Matrix A two-dimensional barcode symbology that is often used for pharmaceutical product labeling and tracking.
- Near Field Communication (NFC) Enables communication between NFC-enabled devices and pharmaceutical products for tracking and authentication purposes.
- Others This may include emerging traceability technologies or hybrid solutions combining various tracking methods.
Pharmaceutical Traceability Market, By Product Type
- Hardware Includes physical components such as barcode scanners, RFID readers, printers, and other equipment used for traceability purposes.
- Software Encompasses track and trace software, serialization software, data management platforms, and other digital solutions.
- Services Comprises consulting, implementation, training, support, and maintenance services related to pharmaceutical traceability solutions.
Pharmaceutical Traceability Market, By Application
- Serialization Involves assigning unique identifiers to individual units or batches of pharmaceutical products.
- Aggregation Refers to the process of grouping individual units into larger containers or packages for traceability purposes.
- Tracking Involves monitoring the movement and location of pharmaceutical products throughout the supply chain.
- Monitoring Includes real-time monitoring of environmental conditions, such as temperature and humidity, during the transportation and storage of pharmaceutical products.
- Authentication Ensures the authenticity and integrity of pharmaceutical products through verification mechanisms.
- Others Additional applications or functionalities related to pharmaceutical traceability.
Pharmaceutical Traceability Market, By Geography
- North America Market conditions and demand in the United States, Canada, and Mexico.
- Europe Analysis of the Pharmaceutical Traceability Market in European countries.
- Asia-Pacific Focusing on countries like China, India, Japan, South Korea, and others.
- Middle East and Africa Examining market dynamics in the Middle East and African regions.
- Latin America Covering market trends and developments in countries across Latin America.
Key Players
The major players in the Pharmaceutical Traceability Market are
- TraceLink, Inc.
- Adents
- SATO VICINITY
- Axway Corporation
- OPTEL GROUP
- Marchesini Group S.p.A.
- ACG (India)
- Avery Dennison Corporation
- Cognex Corporation
- Datalogic S.p.A.
- Impinj, Inc.
- Zebra Technologies Corporation
- Alien Technology
- AlpVision
- Data Management and Analytics
- Antares Vision S.p.A.
- Authentix, Inc.
- Syntegon Technology GmbH
- Bar Code Integrators
- SMARTRAC Technology, Inc
Report Scope
REPORT ATTRIBUTES | DETAILS |
---|---|
STUDY PERIOD | 2020-2030 |
BASE YEAR | 2023 |
FORECAST PERIOD | 2024-2030 |
HISTORICAL PERIOD | 2020-2022 |
UNIT | Value (USD Billion) |
KEY COMPANIES PROFILED | TraceLink, Inc Adents, SATO VICINITY, Axway Corporation, OPTEL GROUP, ACG (India), Avery Dennison Corporation, Cognex Corporation, Datalogic S.p.A., Zebra Technologies Corporation. |
SEGMENTS COVERED | By Technology Type, By Product Type, By Application, And By Geography. |
CUSTOMIZATION SCOPE | Free report customization (equivalent to up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope. |
Top Trending Reports
Research Methodology of Market Research
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .
Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support
Customization of the Report
• In case of any please connect with our sales team, who will ensure that your requirements are met.